NO314784B1 - Vekstfremmende kompleks som gir langvarig frigjöring av et somatotropin ogen fremgangsmåte for tilveiebringelse av forlenget frigjöring avet somatotropin - Google Patents

Vekstfremmende kompleks som gir langvarig frigjöring av et somatotropin ogen fremgangsmåte for tilveiebringelse av forlenget frigjöring avet somatotropin Download PDF

Info

Publication number
NO314784B1
NO314784B1 NO19944782A NO944782A NO314784B1 NO 314784 B1 NO314784 B1 NO 314784B1 NO 19944782 A NO19944782 A NO 19944782A NO 944782 A NO944782 A NO 944782A NO 314784 B1 NO314784 B1 NO 314784B1
Authority
NO
Norway
Prior art keywords
somatotropin
complex
approx
pst
release
Prior art date
Application number
NO19944782A
Other languages
English (en)
Norwegian (no)
Other versions
NO944782L (no
NO944782D0 (no
Inventor
Michael T Clark
Robert J Gyurik
Sharon K Lewis
Marianne C Murray
Matthew J Raymond
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO944782L publication Critical patent/NO944782L/no
Publication of NO944782D0 publication Critical patent/NO944782D0/no
Publication of NO314784B1 publication Critical patent/NO314784B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cultivation Of Plants (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19944782A 1992-06-11 1994-12-09 Vekstfremmende kompleks som gir langvarig frigjöring av et somatotropin ogen fremgangsmåte for tilveiebringelse av forlenget frigjöring avet somatotropin NO314784B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/896,958 US5198422A (en) 1992-06-11 1992-06-11 Stabilized somatotropin for parenteral administration
PCT/US1993/005659 WO1993025222A1 (fr) 1992-06-11 1993-06-11 Somatotropine stabilisee pour administration parentale

Publications (3)

Publication Number Publication Date
NO944782L NO944782L (no) 1994-12-09
NO944782D0 NO944782D0 (no) 1994-12-09
NO314784B1 true NO314784B1 (no) 2003-05-26

Family

ID=25407118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19944782A NO314784B1 (no) 1992-06-11 1994-12-09 Vekstfremmende kompleks som gir langvarig frigjöring av et somatotropin ogen fremgangsmåte for tilveiebringelse av forlenget frigjöring avet somatotropin

Country Status (20)

Country Link
US (1) US5198422A (fr)
EP (1) EP0644770B1 (fr)
JP (1) JP3247380B2 (fr)
KR (1) KR100269896B1 (fr)
CN (1) CN1069214C (fr)
AT (1) ATE175355T1 (fr)
AU (1) AU670805B2 (fr)
CA (1) CA2137677C (fr)
DE (1) DE69322958T2 (fr)
DK (1) DK0644770T3 (fr)
ES (1) ES2125990T3 (fr)
GR (1) GR3029291T3 (fr)
HU (1) HU223944B1 (fr)
IL (1) IL105958A (fr)
NO (1) NO314784B1 (fr)
NZ (1) NZ253914A (fr)
PL (1) PL175971B1 (fr)
TW (1) TW341513B (fr)
WO (1) WO1993025222A1 (fr)
ZA (1) ZA934100B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949350B (en) 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
ID27131A (id) * 1998-06-26 2001-03-01 Pfizer Prod Inc Proses yang lebih baik untuk membuat hasil adisi basa schiff dari amina dengan o-hidroksi aldehida dan komposisi materi yang didasarkan padanya
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
JP2001316294A (ja) * 2000-03-14 2001-11-13 Pfizer Prod Inc ｏ−バニリンおよびｏ−バニリン／テトラメチルクロマニルカルボン酸化合物の組み合わせの使用法
CN100369953C (zh) * 2002-09-09 2008-02-20 尼克塔治疗亚拉巴马公司 水溶性聚合物链烷醛
CA2512052C (fr) 2002-12-31 2016-06-21 Altus Pharmaceuticals Inc. Cristaux d'hormone de croissance humaine et procedes de preparation correspondants
JP2006523609A (ja) * 2002-12-31 2006-10-19 アルタス ファーマシューティカルズ インコーポレイテッド タンパク質結晶およびイオン性ポリマーの複合体
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
CA2963784A1 (fr) 2007-06-08 2008-12-18 Mannkind Corporation Inhibiteurs d'ire-1.alpha
ITMI20130341A1 (it) 2013-03-07 2014-09-08 Gm Morando S R L Sistema schermante modulare
WO2017131214A1 (fr) * 2016-01-29 2017-08-03 日産化学工業株式会社 Composition absorbable par voie transdermique permettant la libération contrôlée d'un principe actif hydrosoluble

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1296253C (fr) * 1986-10-20 1992-02-25 Praveen Tyle Compositions d'hormones de croissance stabilisees
EP0374120A3 (fr) * 1988-12-13 1991-07-31 Monsanto Company Composition pour la libération contrôlée des polypeptides
US5015627A (en) * 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration

Also Published As

Publication number Publication date
IL105958A0 (en) 1993-10-20
AU670805B2 (en) 1996-08-01
HUT68917A (en) 1995-08-28
NO944782L (no) 1994-12-09
DK0644770T3 (da) 1999-08-30
IL105958A (en) 1997-11-20
NO944782D0 (no) 1994-12-09
CN1069214C (zh) 2001-08-08
JPH07508003A (ja) 1995-09-07
DE69322958D1 (de) 1999-02-18
ES2125990T3 (es) 1999-03-16
NZ253914A (en) 1997-12-19
PL175971B1 (pl) 1999-03-31
JP3247380B2 (ja) 2002-01-15
TW341513B (en) 1998-10-01
CN1085804A (zh) 1994-04-27
HU223944B1 (hu) 2005-03-29
ZA934100B (en) 1994-06-10
AU4535493A (en) 1994-01-04
ATE175355T1 (de) 1999-01-15
HU9403548D0 (en) 1995-02-28
KR100269896B1 (ko) 2000-10-16
GR3029291T3 (en) 1999-05-28
CA2137677A1 (fr) 1993-12-23
CA2137677C (fr) 1998-08-25
WO1993025222A1 (fr) 1993-12-23
EP0644770A4 (fr) 1995-10-25
EP0644770A1 (fr) 1995-03-29
EP0644770B1 (fr) 1999-01-07
US5198422A (en) 1993-03-30
DE69322958T2 (de) 1999-05-27

Similar Documents

Publication Publication Date Title
US5015627A (en) Stabilized somatotropin for parenteral administration
CA2274596C (fr) Compositions et procedes servant a ameliorer le fonctionnement gastro-intestinal
EP0201219B1 (fr) Compositions favorisant la croissance
EP0289186A2 (fr) Procédé pour augmenter le taux de croissance et l'efficacité nutritive chez le bétail de boucherie
US4837202A (en) Method for stimulating the immune system
US5198422A (en) Stabilized somatotropin for parenteral administration
Cravener et al. Effect of subcutaneous infusion of pituitary-derived chicken growth hormone on growth performance of broiler pullets
US6194384B1 (en) Long-acting galenical formulation for GRF peptides
Rubinstein et al. The growth stimulating effect of small doses of testosterone propionate in the castrate albino rat
Slaba et al. Plasma profiles of somatotropin and IGF-I in dairy cows following application of two preparations of recombinant bovine somatotropin in a sustained release vehicle
CN106883288B (zh) 一种抗菌肽bv21及其用途
AU642871B2 (en) Somatotropin for increasing fertility in animals
US5017560A (en) Poultry growth promotion
EP0217572A2 (fr) Amélioration de la qualité de carcasse
Wiedermann et al. Regulation of myeloid phagocyte development and function by growth hormone: a review.
FARMER et al. Biological activity of bullfrog growth hormone in the rat and the bullfrog (Rana catesbeiana)
US5028591A (en) Method for stimulating the immune system
JP3040116B2 (ja) 食肉の品質改良
US5053391A (en) Composition containing polypeptide hormone for stimulating skeletal growth in poultry
RU2073461C1 (ru) Способ повышения продуктивности молодняка овец
RU1801012C (ru) Способ выращивани тел т
RU2204899C2 (ru) Способ повышения воспроизводительной способности ремонтных свинок
RU1782515C (ru) Способ кормлени свиней
NZ501916A (en) Use of somatotropin to treat cracked hooves and to accelerate animal hoof growth

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees